US FDA approves etravirine for HIV combination therapy
Monday, January 21, 2008 09:00 IST Bridgewater, New Jersey
The US Food and Drug Administration (FDA) has granted accelerated approval to the anti-HIV medication Intelence (etravirine) tablets -- the first non-nucleoside reverse transcriptase inhibitor (NNRTI) to show antiviral activity
